The Ethics of Making Babies: Genetic Selection and Gene Editing

It may sound like science fiction, but reproduction has entered a complex new reality. It is now possible to select IVF embryos based on genetic predictions for diseases and other traits. And the same gene-editing technology that allows scientists to treat patients with sickle cell disease could one day make it possible to change the genes of future children and generations.

The question is no longer what can we do...it's what should we do?

Join us for a fascinating discussion with three experts as they discuss the latest in gene-editing capabilities.

We'll learn about the difference between somatic vs. germline editing, meaning treating a living patient where changes don't pass onto future generations, or editing an embryo so changes do pass on to all future generations. And in each category, there is still more complexity about what is considered "ethical."

What diseases should we treat for living patients?

What are the long-term potential impacts on global health?

How should we make decisions about selecting against or "editing out" diseases at the embryo stage?

How will this affect the diversity of communities in this world? (e.g., disabilities, LGBTQ)

This technology is here and holds a lot of potential. Let's find out where to draw that line together.